Bnp Paribas Asset Management Holding S.A. Biogen Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

$38.7 Billion
Q2 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 432,842 shares of BIIB stock, worth $75.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

432,842

Previous 570,533 24.13%

Holding current value

$75.2 Million

Previous $123 Million 18.44%

% of portfolio

0.26%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$190.52 - $236.72 $26.2 Million - $32.6 Million	-137,691 Reduced 24.13%	432,842 $100 Million
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $25.9 Million - $32.7 Million	122,101 Added 27.23%	570,533 $123 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $47.2 Million - $56.8 Million	-212,114 Reduced 32.11%	448,432 $116 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $27.6 Million - $31.1 Million	108,841 Added 19.73%	660,546 $170 Million
Q2 2023 Aug 08, 2023	BUY	$275.25 - $318.06 $39.3 Million - $45.4 Million	142,793 Added 34.92%	551,705 $157 Million
Q1 2023 May 08, 2023	BUY	$256.56 - $292.34 $6.03 Million - $6.87 Million	23,502 Added 6.1%	408,912 $114 Million
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $9.8 Million - $11.9 Million	38,818 Added 11.2%	385,410 $107 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $284,636 - $392,488	-1,462 Reduced 0.42%	346,592 $92.5 Million
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $194,478 - $231,271	1,037 Added 0.3%	348,054 $71 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $20 Million - $25.2 Million	103,355 Added 42.42%	347,017 $73.1 Million
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $13.3 Million - $17.1 Million	-59,318 Reduced 19.58%	243,662 $58.5 Million
Q3 2021 Nov 08, 2021	BUY	$282.99 - $369.05 $11.8 Million - $15.4 Million	41,710 Added 15.96%	302,980 $85.7 Million
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $7.24 Million - $11.6 Million	-27,970 Reduced 9.67%	261,270 $90.5 Million
Q1 2021 May 05, 2021	BUY	$242.95 - $284.63 $7.41 Million - $8.69 Million	30,519 Added 11.8%	289,240 $80.9 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $1.99 Million - $2.99 Million	8,414 Added 3.36%	258,721 $63.4 Million
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $24.8 Million - $28.6 Million	93,491 Added 59.62%	250,307 $71 Million
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $3.11 Million - $4.12 Million	-12,034 Reduced 7.13%	156,816 $42 Million
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $1.11 Million - $1.41 Million	4,128 Added 2.51%	168,850 $53.4 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $5.03 Million - $6.95 Million	22,849 Added 16.11%	164,722 $48.9 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $8.31 Million - $9.32 Million	38,227 Added 36.88%	141,873 $33 Million
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $9.23 Million - $10.2 Million	-42,081 Reduced 28.88%	103,646 $24.2 Million
Q1 2019 Apr 26, 2019	BUY	$216.71 - $338.96 $5.48 Million - $8.57 Million	25,275 Added 20.98%	145,727 $34.4 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $3.29 Million - $4.17 Million	11,830 Added 10.89%	120,452 $35.4 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $4.57 Million - $5.98 Million	15,576 Added 16.74%	108,622 $38.4 Million
Q2 2018 Aug 01, 2018	SELL	$257.52 - $306.91 $4.66 Million - $5.56 Million	-18,107 Reduced 16.29%	93,046 $27 Million
Q1 2018 May 07, 2018	BUY	$260.13 - $367.91 $5.4 Million - $7.64 Million	20,757 Added 22.96%	111,153 $30.4 Million
Q4 2017 Feb 01, 2018	BUY	$307.64 - $344.58 $4.51 Million - $5.05 Million	14,655 Added 19.35%	90,396 $28.8 Million
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $21.3 Million - $25 Million	75,741	75,741 $23.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Biogen Inc. Transaction History